Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Advertisement

Irish startup to develop breakthrough biotechnology test for major US clinic

Inform Bioscience will sign the agreement with Mayo Clinic next week to develop a test to detect preeclampsia in pregnancy.

Image: Urine sample via Shutterstock

AN IRISH COMPANY are set to sign a license agreement with a world renowned American clinic to develop a test to detect preeclampsia in pregnancy.

Mayo Clinic is a US non-profit worldwide leader in medical care, research and education.

Irish biotech startup, Inform Bioscience, will sign the agreement with Mayo Clinic next week to develop a test to detect preeclampsia much earlier in pregnancy.

It plans to develop a simple urine test using biomarker technology that has the potential to revolutionise prenatal care programmes globally.

Preeclampsia affects three million mothers worldwide every year and is associated with premature births and infant illness including cerebral palsy, blindness, epilepsy, deafness and lung conditions.

There is no effective detection method for the risk of preeclampsia and the cause is unknown.

Making a difference

A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

For the price of one cup of coffee each week you can make sure we can keep reliable, meaningful news open to everyone regardless of their ability to pay.

A number of Senior Executives from the Mayo Clinic will travel to Ireland from the USA to sign the licence agreement with Inform Bioscience in the Biomedical Diagnostics Institute at DCU, Dublin.

The licensing agreement is also supported by Enterprise Ireland.

Read: Royalty gives up bid for Irish biotech firm Elan>

Read: Pharmaceutical firm announces €44m investment in Waterford plant>

About the author:

Read next:

COMMENTS (6)